The Palantine, Illinois-based company, Acura Pharmaceuticals, today launched a new nasal decongestant product formulated to prevent its use in the illicit synthesis of methamphetamine.
FORBES: Acura Pharmaceuticals Launches Meth-Resistant Pseudoephedrine, Nexafed